Field Trip Health Ltd. (FTRP)
Field Trip Health Ltd. operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.84, up 1.07% on the session, giving a market capitalisation of $9.8M. On trailing twelve-month figures it carries a trailing P/E of -0.14, a net margin of -1147.9%. Its beta of 0.00 implies it has historically moved less than the broad market.
Field Trip Health Ltd., established in 2008 and based in Toronto, Canada, specializes in developing and delivering psychedelic-based therapeutic treatments across North America. The company operates dedicated Field Trip Health Centres providing these therapies, offers digital support through Field Trip Digital applications, and conducts pharmaceutical research via its Field Trip Discovery division, which focuses on creating next-generation psychedelic compounds. Additionally, Field Trip Health Ltd. provides ketamine-assisted therapy to help individuals manage depression, anxiety, addiction, and other related conditions.
Field Trip Health Ltd. is most often compared with the following Healthcare names: